Palatin Technologies
PTN
#10740
Rank
C$25.2 M
Marketcap
C$14.17
Share price
-1.54%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -C$8.46 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$12.88 Million. In 2025 the company made an earning of -C$13.35 Million, an increase over its 2024 earnings that were of -C$37.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$8.46 Million-36.68%
2025 -C$13.35 Million-64.29%
2024 -C$37.38 Million-16.9%
2023 -C$44.98 Million5.99%
2022 -C$42.44 Million-13.7%
2021 -C$49.18 Million33.25%
2020 -C$36.91 Million-172.11%
2019 C$51.17 M2352.33%
2018 C$2.08 M-94.13%
2017 C$35.55 M-154.92%
2016 -C$64.75 Million3.67%
2015 -C$62.46 Million878%
2014 -C$6.39 Million-72.64%
2013 -C$23.34 Million-33.11%
2012 -C$34.9 Million77.71%
2011 -C$19.64 Million
2003 -C$33.25 Million29.93%
2002 -C$25.59 Million36.18%
2001 -C$18.79 Million
1999 -C$15.6 Million6.04%
1998 -C$14.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.04 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.34 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.10 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.26 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.26 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.16 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$40.92 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$80.4 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA